11β-Hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response
The DOI matches its Crossref record; 398 of the 412 references it cites were found in a registry or an index.
Abstract
11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) interconverts inactive cortisone and active cortisol. Although bidirectional, in vivo it is believed to function as a reductase generating active glucocorticoid at a prereceptor level, enhancing glucocorticoid receptor activation. In this review, we discuss both the genetic and enzymatic characterization of 11beta-HSD1, as well as describing its role in physiology and pathology in a tissue-specific manner. The molecular basis of cortisone reductase deficiency, the putative "11beta-HSD1 knockout state" in humans, has been defined and is caused by intronic mutations in HSD11B1 that decrease gene transcription together with mutations in hexose-6-phosphate dehydrogenase, an endoluminal enzyme that provides reduced nicotinamide-adenine dinucleotide phosphate as cofactor to 11beta-HSD1 to permit reductase activity. We speculate that hexose-6-phosphate dehydrogenase activity and therefore reduced nicotinamide-adenine dinucleotide phosphate supply may be crucial in determining the directionality of 11beta-HSD1 activity. Therapeutic inhibition of 11beta-HSD1 reductase activity in patients with obesity and the metabolic syndrome, as well as in glaucoma and osteoporosis, remains an exciting prospect.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cortisone and prednisone are inactive prohormones that must be reduced to cortisol or prednisolone by hepatic 11HSD1 to bind to and activate the glucocorticoid receptor (GR) (45, 587).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [587]
In the citing paper
“other health outcomes associated with better quality of life improved, including sleep apnoea136 and mobility137.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [136]
In the citing paper
“the glucocorticoid sensitivity may be different among the different individuals and among the different tissues in the same individual, due also to polymorphisms of both glucocorticoid receptor (25)(26)(27)(28) and 11-hydroxysteroid-dehydrogenase type 1 genes (29,30).”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [29]
In the citing paper
“HSD11B2 functions exclusively as an oxidative enzyme, inactivating cortisol to cortisone [108].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [108]
In the citing paper
“while 17OHP and cortisol can be either 5α- or 5β-reduced, 11-deoxycortisol and cortisone are predominantly 5β-reduced [108].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [108]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Sapolsky, R. M., Romero, L. M., & Munck, A. U. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.1.0389 · Cited by 7,541 · cited 1×
“Immunomodulation represents an important facet of glucocorticoid physiology and inflammation therapy and is manifested by the regulation of cytokine production and immune cell function (324).”
Sapolsky, R. M. (2000) · Endocrine Reviews · doi:10.1210/er.21.1.55 · Cited by 7,533
A transgenic model of visceral obesity and the metabolic syndrome
Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S. (2001) · Science · doi:10.1126/science.1066285 · Cited by 1,766 · cited 1×
“Mice overexpressing 11 -HSD1 under the aP2 promoter have enhanced adipocyte differentiation (as measured by increased fat cell size) as a consequence of increased adipose tissue corticosteroid concentrations (139) (see Section VII.”
Short-chain dehydrogenases/reductases (SDR)
Jörnvall, H., Persson, B., Krook, M., Atrian, S., Gonzalez-Duarte, R., Jeffery, J., & Ghosh, D. (1995) · Biochemistry · doi:10.1021/bi00018a001 · Cited by 1,249 · cited 3×
“Also known as short-chain alcohol dehydrogenases (35) or sec (secondary) alcohol dehydrogenases (36), members of this family were originally classified as having 250–300 residues (classical family) with an N-terminal cofactor-binding domain and a centrally located active site, although some enzymes now have more than…”
Edwards, C. R. W., Burt, D., Mcintyre, M. A., De Kloet, E. R., Stewart, P. M., Brett, L., Sutanto, W. S., & Monder, C. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90742-8 · Cited by 1,068
Self-citationCole, T. J., Blendy, J. A., Monaghan, A. P., Krieglstein, K., Schmid, W., Aguzzi, A., Fantuzzi, G., Hummler, E., Unsicker, K., & Schütz, G. (1995) · Genes & Development · doi:10.1101/gad.9.13.1608 · Cited by 946 · cited 1×
“Within the fetal rat lung, corticosteroids increased 11-oxoreductase activity, which in turn resulted in an increase in surfactant synthesis (71), a glucocorticoiddependent process (336) essential for normal lung maturation.”
Impaired Energy Homeostasis in C/EBPα Knockout Mice
Wang, N.-D., Finegold, M. J., Bradley, A., Ou, C. N., Abdelsayed, S. V., Wilde, M. D., Taylor, L. R., Wilson, D. R., & Darlington, G. J. (1995) · Science · doi:10.1126/science.7652557 · Cited by 929
Kotelevtsev, Y., Holmes, M. C., Burchell, A., Houston, P. M., Schmoll, D., Jamieson, P., Best, R., Brown, R., Edwards, C. R. W., Seckl, J. R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14924 · Cited by 858
Stewart, P., Valentino, R., Wallace, A. M., Burt, D., Shackleton, C. L., & Edwards, C. W. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91014-2 · Cited by 803
Self-citationANTI-ESCHERICHIA COLI ALPHA-HAEMOLYSIN IN CONTROL AND PATIENT SERA
Emody, L., Batai, I., Kerényi, M., Székely, J., & Polyak, L. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90183-0 · Cited by 800
Research works printed but not linked: 6
- Bush, 1969, 11β-Hydroxysteroid dehydrogenase: contrast between studies in vivo and studies in vitro., Adv Biosci, 3, 23
- Taylor, 1990, Corticosteroid 11-reductase deficiency: steroid studies in a further family, J Clin Invest, 13, P238
- Burtt, 2003, Haplotype-based association studies of HSD11B1 and abdominal obesity, 117
- Bujalska, 2000, Glucocorticoids, 11β-hydroxysteroid dehydrogenase and obesity, 158
- Taylor, 1984, Cortisone reductase deficiency: evidence for a new inborn error in metabolism of adrenal steroids, J Endocrinol, 102, 89
- Savage, 1991, Increased metabolic clearance of cortisol in corticosteroid 11-reductase deficiency, J Endocrinol, 129, 219
Cited by
Items 401–500 of 1,000
Kardon, T., Senesi, S., Marcolongo, P., Legeza, B., Bánhegyi, G., Mandl, J., Fulceri, R., & Benedetti, A. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.04.045 · Cited by 28
Lepifre, F., Christmann‐Franck, S., Roche, D., Leriche, C., Carniato, D., Charon, C., Hallakou‐Bozec, S., Doaré, L., Schmidlin, F., Lecomte, M., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.02.123 · Cited by 29
Marcolongo, P., Senesi, S., Gava, B., Fulceri, R., Sorrentino, V., Margittai, É., Lizák, B., Csala, M., Bánhegyi, G., & Benedetti, A. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.05.027 · Cited by 32
Dovio, A., Roveda, E., Sciolla, C., Montaruli, A., Raffaelli, A., Saba, A., Calogiuri, G., Francia, S. D., Borrione, P., Salvadori, P. A., et al. (2009) · European Journal of Applied Physiology · doi:10.1007/s00421-009-1265-5 · Cited by 28
“…is known, moreover, that physical exercise causes an increase of circulating IL-6 (Minetto et al. 2005), likely due to spill over from working muscles, not to say that IL-6 activates HPA axis (Mastorakos et al. 1993) and increases 11bHSD1 activity in a number of cell types (Tomlinson et al. 2004).”
InfluentialHong, D., Li, X., Lian, Q., Lamba, P., Bernard, D. J., Hardy, D. O., Chen, H., & Ge, R. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.08.134 · Cited by 28
Zhang, J., Li, J., Xu, Y., Yang, J., Chen, Z., & Deng, H. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.08.022 · Cited by 29
Espíndola-Antunes, D., & Kater, C. E. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000800027 · Cited by 33
Shang, F., Liu, M., Li, B., Zhang, X., Sheng, Y., Liu, S., Han, J., Li, H., & Xiu, R. (2016) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-016-3030-x · Cited by 32
Kovačević, S., Brkljačić, J. M., Matić, G. M., & Elaković, I. (2018) · Neuroendocrinology · doi:10.1159/000496391 · Cited by 28
Böhme, T., Engel, C. K., Farjot, G., Güssregen, S., Haack, T., Tschank, G., & Ritter, K. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.05.102 · Cited by 28
Assessment of tissue cortisol activity
Cohen, J., & Venkatesh, B. (2009) · Critical Care and Resuscitation · doi:10.1016/s1441-2772(23)01291-7 · Cited by 28
The Adrenal Cortex and Its Disorders
Miller, W. L., Achermann, J. C., & Flück, C. E. (2008) · Elsevier eBooks · doi:10.1016/b978-141604090-3.50017-x · Cited by 33
Ergang, P., Vodička, M., Soták, M., Klusoňová, P., Behuliak, M., Řeháková, L., Zach, P., & Pácha, J. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.12.013 · Cited by 28
Eller, O. C., Morris, E. M., Thyfault, J. P., & Christianson, J. A. (2020) · Physiology & Behavior · doi:10.1016/j.physbeh.2020.113000 · Cited by 28
Chen, H. C., Yip, T., Lee, J. K., Juliani, J., Sernia, C., Hill, A. F., Lavidis, N. A., & Spiers, J. G. (2020) · Antioxidants · doi:10.3390/antiox9090853 · Cited by 30
Liu, W., Katz, D. A., Locke, C. S., Daszkowski, D., Wang, Y., Rieser, M. J., Awni, W. M., Marek, G. J., & Dutta, S. (2013) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.5 · Cited by 31
Gaware, R., Khunt, R. C., Czollner, L., Stanetty, C., Cunha, T. D., Kratschmar, D. V., Odermatt, A., Kosma, P., Jordis, U., & Classen-Houben, D. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.02.005 · Cited by 31
Draper, N., Powell, B. L., Franks, S., Conway, G. S., Stewart, P. M., & McCarthy, M. I. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02547.x · Cited by 27
Self-citationYang, Q., Wang, W., Liu, C., Wang, Y., & Sun, K. (2016) · Reproductive Toxicology · doi:10.1016/j.reprotox.2016.06.003 · Cited by 28
Iliadis, S. I., Comasco, E., Hellgren, C., Kollia, N., Poromaa, I. S., & Skalkidou, A. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.09.030 · Cited by 30
“The 11β-HSD1 protein is expressed in many tissues, including the hypothalamus and pituitary (Tomlinson et al., 2004), and regulates central-HPA axis activity.”
Salehzadeh, F., Al‐Khalili, L., Kulkarni, S. S., Wang, M., Lönnqvist, F., & Krook, A. (2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.944 · Cited by 33
“Insulin-sensitive tissues such as adipose tissue and liver have been implicated to play an important role in mediating the deleterious effects of excess glucocorticoids on whole body glucose homeostasis [28].”
Differential Modulation of 3T3-L1 Adipogenesis Mediated by 11β-Hydroxysteroid Dehydrogenase-1 Levels
Kim, J., Temple, K. A., Jones, S. A., Meredith, K. N., Basko, J. L., & Brady, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m606197200 · Cited by 29
Nammi, S., Dembélé, K., & Nyomba, B. L. G. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00255.2006 · Cited by 27
TETSUKA, M., Nishimoto, H., Miyamoto, A., Okuda, K., & Hamano, S. (2010) · Journal of Reproduction and Development · doi:10.1262/jrd.10-019k · Cited by 27
“In the glucocorticoid target organs, 11HSD1 acts primarily as a NADPH-dependent reductase [9, 25].”
Li, X., Hu, S., Zhu, Q., Yao, G., Yao, J., Li, J., Wang, Y., Ding, Y., Qi, J., Xu, R., et al. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154749 · Cited by 26
Stimulation of 11β-HSD1 expression by IL-1β via a C/EBP binding site in human fetal lung fibroblasts
Yang, Z. H., Zhu, X.-O., Guo, C., & Sun, K. (2009) · Endocrine · doi:10.1007/s12020-009-9245-4 · Cited by 26
Gene Expression and miR Profiles of Human Corneal Fibroblasts in Response to Dexamethasone
Liu, L., Walker, E. A., Kissane, S., Khan, I. J., Murray, P. I., Rauz, S., & Wallace, G. R. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-7463 · Cited by 27
Self-citationThe (+)- and (−)-gossypols potently inhibit human and rat 11β-hydroxysteroid dehydrogenase type 2
Chen, B., Lin, H., Hu, G., Su, Y., Zhou, H., Lian, Q., Cai, H., Hardy, D. O., Gu, D., & Ge, R. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.12.006 · Cited by 26
Goldberg, F. W., Dossetter, A. G., Scott, J. S., Robb, G. R., Boyd, S., Groombridge, S. D., Kemmitt, P. D., Sjögren, T., Gutierrez, P. M., deSchoolmeester, J., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4016729 · Cited by 26
Zhou, J., Zhang, J., Luo, X., Li, M., Yue, Y., Laudon, M., Jia, Z., & Zhang, R. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.07.001 · Cited by 27
Garcêz, A., Leite, H. M., Weiderpass, E., Paniz, V. M. V., Watte, G., Canuto, R., & Olinto, M. T. A. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.05.023 · Cited by 30
Synthesis and biological evaluation of heterocycle containing adamantane 11β-HSD1 inhibitors
Yeh, V. S. C., Patel, J. R., Yong, H., Kurukulasuriya, R., Fung, S., Monzon, K., Chiou, W. J. H., Wang, J., Stolarik, D. F., Imade, H. M., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.07.055 · Cited by 26
Molecular Mechanisms of Corticosteroid Resistance
Tonello, A., & Poli, G. (2009) · CHEST Journal · doi:10.1378/chest.08-2385 · Cited by 26
Balázs, Z., Nashev, L. G., Chandsawangbhuwana, C., Baker, M. E., & Odermatt, A. (2008) · Nature Precedings · doi:10.1016/j.mce.2008.10.021 · Cited by 26
“In addition, both 11βHSD1 reductase and dehydrogenase activities have been measured in Leydig cells (Latif et al., 2005, Tomlinson et al., 2004), despite colocalization with H6PDH in these cells (Gomez- Sanchez et al., 2008).”
Khashana, A., Ojaniemi, M., Leskinen, M., Saarela, T., & Hallman, M. (2015) · Acta Paediatrica · doi:10.1111/apa.13257 · Cited by 26
The Role of 11ß-Hydroxysteroid Dehydrogenase 1 in Adipogenesis in Thyroid-Associated Ophthalmopathy
Tomlinson, J., Durrani, O. M., Bujalska, I. J., Gathercole, L., Tomlins, P. J., Reuser, T. T. Q., Rose, G. E., Curnow, J., Stewart, P. M., Walker, E. A., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0873 · Cited by 29
Self-citationDuan, Y., Fu, W., Wang, S., Ni, Y., & Zhao, R. (2014) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2014.07.010 · Cited by 26
Involvement of GR and p300 in the Induction of H6PD by Cortisol in Human Amnion Fibroblasts
Wang, W., Guo, C., Li, W., Li, J., Wang, W., Myatt, L., & Sun, K. (2012) · Endocrinology · doi:10.1210/en.2012-1531 · Cited by 25
Biason‐Lauber, A., Boscaro, M., Mantero, F., & Balercia, G. (2010) · Journal of Endocrinological Investigation · doi:10.1007/bf03346683 · Cited by 25
Sun, D., Wang, Z., Cardozo, M. G., Choi, R. J., DeGraffenreid, M. R., Di, Y., He, X., Jaén, J. C., Labelle, M., Liu, J., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.12.114 · Cited by 25
Diminished adrenal sensitivity and ACTH efficacy in obese premenopausal women
Roelfsema, F., Pijl, H., Keenan, D. M., & Veldhuis, J. D. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0592 · Cited by 24
Sakamuri, S. S. V. P., Anamthathmakula, P., Giridharan, N. V., & Vajreswari, A. (2011) · Nutrition Journal · doi:10.1186/1475-2891-10-70 · Cited by 25
“11b-HSD1 gene expression in liver and adipose tissue is also regulated by various hormones and cytokines present in the plasma [ 24 ].”
Yang, Q., Wang, W., Liu, C., Wang, Y., & Sun, K. (2016) · Placenta · doi:10.1016/j.placenta.2016.08.079 · Cited by 25
Kundap, U. P., Paudel, Y. N., & Shaikh, M. F. (2020) · Pharmaceuticals · doi:10.3390/ph13060106 · Cited by 27
Nakayama, S., Nishiyama, M., Iwasaki, Y., Shinahara, M., Okada, Y., Tsuda, M., Okazaki, M., Tsugita, M., Taguchi, T., Makino, S., et al. (2011) · Endocrine Journal · doi:10.1507/endocrj.k10e-370 · Cited by 26
“Local glucocorticoid excess could also occur in the abdominal adipose tissue, when glucocorticoid-activating enzyme (11β-hydroxysteroid dehydrogenase type 1) is overexpressed [8, 9].”
Su, X., Vicker, N., Lawrence, H. R., Smith, A., Purohit, A., Reed, M. J., & Potter, B. V. L. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.03.019 · Cited by 32
Carvajal, C. A., Tapia-Castillo, A., Valdivia, C. P., Allende, F. A., Solari, S., Lagos, C. F., Campino, C., Martínez‐Aguayo, A., Vecchiola, A., Pinochet, C., V, et al. (2018) · American Journal of Hypertension · doi:10.1093/ajh/hpy051 · Cited by 26
Effects of Ziram on Rat and Human 11β-Hydroxysteroid Dehydrogenase Isoforms
Li, X., Mao, B., Dong, Y., Li, Y., Zhan, M., Bai, Y., Lian, Q., Ge, R., & Ye, L. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.5b00527 · Cited by 27
Chiodini, I., Gaudio, A., Eller-Vainicher, C., Morelli, V., Aresta, C., Zhukouskaya, V. V., Merlotti, D., Orsi, E., Barbieri, A. M., Fustinoni, S., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00037 · Cited by 24
Calcium-Deficiency during Pregnancy Affects Insulin Resistance in Offspring
Takaya, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137008 · Cited by 25
Rao, R., Somvanshi, P. R., Klerman, E. B., Marmar, C. R., & Doyle, F. J. (2021) · Metabolites · doi:10.3390/metabo11080483 · Cited by 27
Damjanovic, S. S., Antic, J. A., Ilic, B. B., Čokić, B. B., Ivović, M., Ognjanovic, S. I., Isailovic, T. V., Popovic, B. M., Antić, I. B., Tatic, S. B., et al. (2012) · Molecular Medicine · doi:10.2119/molmed.2012.00261 · Cited by 24
“Overexpression of 11β-HSD1 in all adipose tissues of transgenic mice and visceral adipose expanding are related to increased expression of GRα (22).”
Yuen, K. C. J., Roberts, C. T., Frystyk, J., Rooney, W. D., Pollaro, J., Klopfenstein, B. J., & Purnell, J. Q. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1532 · Cited by 24
Deng, X., Shen, Y., Yang, J., He, J., Zhao, Y., Peng, L., Leng, Y., & Zhao, Q. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.05.010 · Cited by 27
Gómez-Sánchez, E. P., Gomez-Sanchez, M. T., de Rodriguez, A. F., Romero, D. G., Warden, M. P., Plonczynski, M. W., & Gómez-Sánchez, C. E. (2009) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.2009.953059 · Cited by 29
“Without H6PDH activity, 11b-HSD1 acts as a dehydrogenase (Atanasov et al. 2004; Banhegyi et al. 2004; Tomlinson et al. 2004).”
Stewart, P. M. (2005) · Clinical Medicine · doi:10.7861/clinmedicine.5-2-142 · Cited by 35
Self-citationKatz, D. A., Liu, W., Locke, C. S., Dutta, S., & Tracy, K. A. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4089-5 · Cited by 24
Stewart, P. M., & Newell-Price, J. D. C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00015-0 · Cited by 34
Self-citationXu, C., Li, E., Xu, Z., Su, Y., Lu, M., Qin, J. G., Chen, L., & Wang, X. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00254 · Cited by 26
“, 2007), and the 11β-HSD2 gene catalyzes the conversion of cortisol to cortisone (Tomlinson et al., 2004).”
Quantitative Profiling of Cortisol Metabolites in Human Urine by High-Resolution Accurate-Mass Ms
Wang, Y., Fujioka, N., & Xing, C. (2018) · Bioanalysis · doi:10.4155/bio-2018-0182 · Cited by 25
Saba, A., Raffaelli, A., Cupisti, A., Petri, A., Marcocci, C., & Salvadori, P. A. (2008) · Journal of Mass Spectrometry · doi:10.1002/jms.1530 · Cited by 25
Optimization of novel di-substituted cyclohexylbenzamide derivatives as potent 11β-HSD1 inhibitors
McMinn, D. L., Rew, Y., Sudom, A. M., Caille, S., DeGraffenreid, M. R., He, X., Hungate, R. W., Jiang, B., Jaén, J. C., Julian, L. D., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.01.026 · Cited by 28
Pyridine amides as potent and selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1
Wang, H., Ruan, Z., Li, J. J., Simpkins, L. M., Smirk, R. A., Wu, S. C., Hutchins, R. D., Nirschl, D. S., Kirk, K. V., Cooper, C. B., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.04.069 · Cited by 30
Malavasi, E. L. V., Kelly, V., Nath, N., Gambineri, A., Dakin, R. S., Pagotto, U., Pasquali, R., Walker, B. R., & Chapman, K. E. (2009) · Endocrinology · doi:10.1210/en.2009-0663 · Cited by 28
Ahmed, A., Saksena, S., Sherlock, M., Olliff, S. P., Elias, E., & Stewart, P. M. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03125.x · Cited by 24
Self-citationThurston, L. M., Abayasekara, D. R. E., & Michael, A. E. (2007) · Journal of Endocrinology · doi:10.1677/joe.1.07025 · Cited by 29
Nedungadi, D., Ryan, N. M., Anderson, K., Lamenza, F. F., Jordanides, P. P., Swingler, M., Harinantenaina, L., Riedl, K. M., Iwenofu, H., & Oghumu, S. (2021) · Carcinogenesis · doi:10.1093/carcin/bgab118 · Cited by 23
Aykroyd, B. R. L., Tunster, S. J., & Sferruzzi-Perri, A. N. (2022) · Development · doi:10.1242/dev.199811 · Cited by 24
Christakoudi, S., Cowan, D., & Taylor, N. (2011) · Steroids · doi:10.1016/j.steroids.2011.12.018 · Cited by 23
Feldman, K., Szappanos, Á., Butz, H., Grolmusz, V. K., Majnik, J., Likó, I., Kriszt, B., Lakatos, P. L., Tóth, M., Rácz, K., et al. (2012) · Steroids · doi:10.1016/j.steroids.2012.08.014 · Cited by 25
“converting the inactive cortisone into the active cortisol in a tissuespecific manner [3].”
Druce, L. A., Thorpe, C., & Wilton, A. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2007.04.031 · Cited by 25
Targeting of the Drosophila protein CG2254/Ldsdh1 to a subset of lipid droplets
Thul, P. J., Tschapalda, K., Kolkhof, P., Thiam, A. R., Oberer, M., & Beller, M. (2017) · Journal of Cell Science · doi:10.1242/jcs.199661 · Cited by 24
Miguet, L., Zhang, Z., Barbier, M., & Grigorov, M. (2006) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-006-9037-3 · Cited by 26
Can licorice lick colon cancer?
Stewart, P. M., & Prescott, S. M. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38936 · Cited by 23
Self-citationIntravascular Glucocorticoid Metabolism during Inflammation and Injury in Mice
Dover, A. R., Hadoke, P. W. F., Macdonald, L. J., Miller, E., Newby, D. E., & Walker, B. R. (2007) · Endocrinology · doi:10.1210/en.2006-0996 · Cited by 22
Reduced cortisol metabolism during critical illness.
(2013) · New England Journal of Medicine · doi:10.1056/nejmc1306703 · Cited by 23
Yang, H. J., Chen, Y., Li, X., & Xu, D. (2021) · Heart Failure Reviews · doi:10.1007/s10741-021-10158-x · Cited by 22
Shave, S., Blackburn, E. A., Adie, J., Houston, D. R., Auer, M., Webster, S. P., Taylor, P., & Walkinshaw, M. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116570 · Cited by 22
Discovery of orally active butyrolactam 11β-HSD1 inhibitors
Yeh, V. S. C., Kurukulasuriya, R., Fung, S., Monzon, K., Chiou, W. J. H., Wang, J., Stolarik, D. F., Imade, H. M., Shapiro, R. D., Knourek-Segel, V. E., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.08.034 · Cited by 22
UVB induces epidermal 11β‐hydroxysteroid dehydrogenase type 1 activity in vivo
Tiganescu, A., Hupe, M., Jiang, Y. J., Celli, A., Uchida, Y., Mauro, T. M., Bikle, D. D., Elias, P. M., & Holleran, W. M. (2015) · Experimental Dermatology · doi:10.1111/exd.12682 · Cited by 23
Ryu, J. H., Lee, J. A., Kim, S., Shin, Y. A., Yang, J., Han, H. Y., Son, H. J., Kim, Y. H., Sa, J. H., Kim, J.-S., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01122 · Cited by 23
Gant, C. M., Minović, I., Binnenmars, H., de Vries, L. V., Kema, I. P., van Beek, A. P., Navis, G. J., Bakker, S. J. L., & Laverman, G. D. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00088 · Cited by 25
Keller, B., Volkmann, A., Wilckens, T., Moeller, G., & Adamski, J. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.10.025 · Cited by 22
Glucocorticoid Resistance and Hypersensitivity
Malchoff, C. D., & Malchoff, D. M. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.02.002 · Cited by 23
Social defeat stress induces genome-wide 5mC and 5hmC alterations in the mouse brain
Kuehner, J. N., Walia, N. R., Seong, R., Li, Y., Martínez-Feduchi, P., & Yao, B. (2023) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkad114 · Cited by 22
Roche, D., Carniato, D., Leriche, C., Lepifre, F., Christmann‐Franck, S., Grädler, U., Charon, C., Hallakou‐Bozec, S., Doaré, L., Schmidlin, F., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.03.140 · Cited by 22
Ma, R., Liu, J., Wu, L., Sun, J., Zhu, Y., Yu, C., Yuan, P., & Xiao, X. (2012) · Steroids · doi:10.1016/j.steroids.2012.03.007 · Cited by 23
Identification of microRNAs as a potential novel regulatory mechanism in HSD11B1 expression
Han, Y., Staab-Weijnitz, C. A., Xiong, G., & Maser, E. (2012) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2012.09.005 · Cited by 21
Sæves, I., Line, P., & Bergan, S. (2012) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e31825ee3f8 · Cited by 21
Boudon, S. M., Vuorinen, A., Geotti-Bianchini, P., Wandeler, E., Kratschmar, D. V., Heidl, M., Campiche, R., Jackson, E., & Odermatt, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171079 · Cited by 22
Kennedy, E. K. C., & Janz, D. M. (2022) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2022.111352 · Cited by 21
Discontinued drugs in 2012: endocrine and metabolic
Colca, J. R. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2013.829038 · Cited by 21
Thoeringer, C. K., Wultsch, T., Shahbazian, A., Painsipp, E., & Holzer, P. D. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.08.001 · Cited by 24
Altuna, M. E., Lelli, S. M., de Viale, L. C. S. M., & Damasco, M. C. (2006) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y06-046 · Cited by 23
Arpe, M.-L. H., Rørvig, S., Kok, K., Mølgaard, C., & Frandsen, T. L. (2015) · Supportive Care in Cancer · doi:10.1007/s00520-015-2718-5 · Cited by 26
Montskó, G., Tarjányi, Z., Mezősi, E., & Kovács, G. L. (2014) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-014-7642-x · Cited by 22
Miyamoto, Y., Morisaki, H., Yamanaka, I., Kokubo, Y., Masuzaki, H., Okayama, A., Tomoike, H., Nakao, K., Okamura, T., Yoshimasa, Y., et al. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.05.017 · Cited by 23
Frick, J. M., Eller, O. C., Foright, R. M., Levasseur, B. M., Yang, X., Wang, R., Winter, M. K., O’Neil, M. F., Morris, E. M., Thyfault, J. P., et al. (2023) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00216.2022 · Cited by 20
Nethathe, G. D., Lipman, J., Anderson, R., Fuller, P. J., & Feldman, C. H. (2023) · British Journal of Anaesthesia · doi:10.1016/j.bja.2023.10.034 · Cited by 27
Induction of TDO2 and IDO2 in Liver by High-Fat Feeding in Mice: Discrepancies with Human Obesity
Poulain‐Godefroy, O., Eury, E., Leloire, A., Hennart, B., Guillemin, G. J., Allorge, D., & Froguel, P. (2013) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s11717 · Cited by 20
Metadata
- Authors
- Tomlinson, J. W., Walker, E. A., Bujalska, I. J., Draper, N., Lavery, G. G., Cooper, M. S., Hewison, M., & Stewart, P. M.
- Affiliations
- Queen Elizabeth Hospital Birmingham (GB)
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2004-10-01
- Volume
- 25
- Issue
- 5
- Pages
- 831-866
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2016125985
- Semantic Scholar
- 7653c899826b606d61172864887c634e9d76851b
- Cited by
- 969
- References
- 412
- Citations by year
- 2026: 17 · 2025: 22 · 2024: 25 · 2023: 23 · 2022: 32 · 2021: 30 · 2020: 27 · 2019: 34 · 2018: 30 · 2017: 33 · 2016: 38 · 2015: 43 · 2014: 55 · 2013: 65 · 2012: 70
- FWCI
- 7.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- 11β-hydroxysteroid dehydrogenase type 1, glucocorticoid metabolism, hexose-6-phosphate dehydrogenase, NADPH cofactor, tissue-specific gene regulation, obesity, metabolic syndrome, glaucoma, osteoporosis, 11β-HSD1 inhibition
- MeSH terms
- Amino Acid Sequence, Animals, Carbohydrate Dehydrogenases, Cloning, Molecular, Cortisone Reductase, Enzyme Inhibitors, Glaucoma, Glucocorticoids, Humans, Hydrocortisone, Molecular Sequence Data, Mutation, NADP, Obesity, Organ Specificity, Osteoporosis, Recombinant Proteins, Substrate Specificity, Transcription, Genetic, Gene Expression Regulation, Enzymologic, Sequence Alignment, 11-beta-Hydroxysteroid Dehydrogenase Type 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.